Immunovia (NASDAQ Stockholm: IMMNOV), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of the company's next-generation test at the ...

KDEV) today publishes its Interim Report - January-September 2024. The full report is available on the Company's website. “Research progress is an important element and one that generates value in our ...

With reference to the above, Nasdaq Stockholm has decided to delist the ordinary shares, preference shares, class B preference shares and warrants of Oscar Properties Holding AB from Nasdaq ...

STOCKHOLM, Sweden, 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company SVF Vaccines has appointed Dr Gaston Picchio as acting CEO. He will ...

Notification of transaction by a closely associated person of a Director of Millicom (Tigo) Luxembourg, November 13, 2024 – Millicom ...

2024 to holders of Autoliv Swedish Depository Receipts listed on Nasdaq Stockholm, or SDRs. “With only the current quarter remaining under the current share repurchase program, the Autoliv Board of ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued ...

For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or [email protected] Nasdaq Stockholm AB The views and opinions expressed herein ...

The company, which recently rebranded and split from Gaming Innovation Group, is dual listed on the Oslo Stock Exchange and Nasdaq Stockholm. Investors and analysts are invited to a live ...